Results 81 to 90 of about 467,445 (327)
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
New England Journal of Medicine, 2019 BACKGROUND The efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12 and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is unknown.
B. Sands +15 more
semanticscholar +1 more source
State‐of‐the‐Art, Insights, and Perspectives for MOFs‐Nanocomposites and MOF‐Derived (Nano)Materials
Advanced Materials, EarlyView.Different approaches to MOF‐NP composite formation, such as ship‐in‐a‐bottle, bottle‐around‐the‐ship and in situ one‐step synthesis, are used. Owing to synergistic effects, the advantageous features of the components of the composites are beneficially combined, and their individual drawbacks are mitigated.
Stefanos Mourdikoudis +6 more
wiley +1 more source
Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines?
Mediators of Inflammation, 1998 Smoking has either a beneficial or harmful effect on the course and recurrence of ulcerative colitis and Crohn's disease respectively. Transdermal application of nicotine had similar effects in ulcerative colitis and therefore was considered to be an ...
F. J. Zijlstra
doaj +1 more source
The role of the novel Th17 cytokine IL-26 in intestinal inflammation [PDF]
, 2008 Background and aims: Interleukin 26 (IL-26), a novel IL-10-like cytokine without a murine homologue, is expressed in T helper 1 (Th1) and Th17 cells. Currently, its function in human disease is completely unknown. The aim of this study was to analyse its
Auernhammer, Christoph J. +7 more
core +1 more source
Probiotic‐Based Materials as Living Therapeutics
Advanced Materials, EarlyView.Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio +2 more
wiley +1 more source
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
New England Journal of Medicine, 2019 BACKGROUND Biologic therapies are widely used in patients with ulcerative colitis. Head-to-head trials of these therapies in patients with inflammatory bowel disease are lacking.
B. Sands +12 more
semanticscholar +1 more source
Advanced Materials, EarlyView.An ideal implant should mimic native tissues such that it can integrate, sense, heal, and continue to function, i.e., be autonomous. Although early, there are good steps taken in this way, e.g., the development of stimuli‐responsive, self‐powering, self‐actuating, self‐healing, self‐regenerating, and self‐aware implants.
Jagan Mohan Dodda +5 more
wiley +1 more source
Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis [PDF]
, 2011 Peer reviewedPublisher ...
Berry, Susan H +5 more
core +4 more sources
Wireless Capsule Device for Targeted and Safe Tissue Biopsy with Integrated Sensing
Advanced Materials Technologies, EarlyView.This work presents a capsule device featuring a novel magnetically controlled biopsy mechanism for enhanced safety. The biopsy unit integrates a foldable linkage with dual magnets, creating a magnetic attraction–based safeguard, preventing unintended activation during locomotion. A flexible sensor provides real‐time penetration displacement sensing for
Kiyoung Kim +5 more
wiley +1 more source
Hyposplenism in gastro-intestinal disease [PDF]
, 1994 The hazards of living without a spleen were recognised by the paediatricians in the early 1960’s when they focussed attention on the syndrome of fulminant sepsis, often due to pneumococcal infection, occurring in young children within the first two years
Muller, Andre F., Toghill, P. J.
core +1 more source